LONG-TERM EVOLOCUMAB IN ELDERLY PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSIS FROM FOURIER AND FOURIER-OLE

被引：0
|
作者：
Al Said, Samer
O'Donoghue, Michelle L.
Ran, Xinhui
Murphy, Sabina
Flores-Arredondo, Jose
Wang, Bei
Sabatine, Marc Steven
Giugliano, Robert P.
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1551-219
引用
收藏
页码：2078 / 2078
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
    Gregoire, Jean
    Champsi, Salimah
    Jobin, Manon
    Martinez, Laura
    Urbich, Michael
    Rogoza, Raina M.
    ADVANCES IN THERAPY, 2022, 39 (07) : 3262 - 3279
  • [22] Use of a Genetic Risk Score to Predict Coronary and Vascular Events and Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease From the FOURIER Trial
    Marston, Nicholas A.
    Kamanu, Frederick K.
    Nordio, Francesco
    Gurmu, Yared
    Roselli, Carolina
    Sever, Peter S.
    Pedersen, Terje R.
    Keech, Anthony C.
    Wang, Huei
    Pineda, Armando Lira
    Giugliano, Robert
    Lubitz, Steven A.
    Ellinor, Patrick T.
    Sabatine, Marc S.
    Ruff, Christian T.
    CIRCULATION, 2019, 140 (25) : E977 - E977
  • [23] Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data
    Erviti, Juan
    Wright, James
    Bassett, Ken
    Ben-Eltriki, Mohamed
    Jauca, Ciprian
    Saiz, Luis Carlos
    Leache, Leire
    Gutierrez-Valencia, Marta
    Perry, Thomas L.
    BMJ OPEN, 2022, 12 (12):
  • [24] Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
    Sabatine, Marc S.
    De Ferrari, Gaetano M.
    Giugliano, Robert P.
    Huber, Kurt
    Lewis, Basil S.
    Ferreira, Jorge
    Kuder, Julia F.
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Kurtz, Christopher E.
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    CIRCULATION, 2018, 138 (08) : 756 - 766
  • [25] Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
    Jean Grégoire
    Salimah Champsi
    Manon Jobin
    Laura Martinez
    Michael Urbich
    Raina M. Rogoza
    Advances in Therapy, 2022, 39 : 3262 - 3279
  • [26] Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk
    Rabadia, Soniya V.
    Heimberger, Sarah
    Cameron, Natalie A.
    Shahandeh, Negeen
    CURRENT ATHEROSCLEROSIS REPORTS, 2025, 27 (01)
  • [27] Clinical benefit of evolocumab by severity and extent of coronary artery disease: an analysis from FOURIER
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2018, 25 (9-10): : 267 - 267
  • [28] Effects of Evolocumab in Patients With Prior Percutaneous Coronary Intervention: An Analysis From the Fourier Trial
    Furtado, Remo H.
    Fagundes, Antonio A., Jr.
    Oyama, Kazuma
    Zelniker, Thomas A.
    Tang, Minao
    Kuder, Julia F.
    Murphy, Sabina A.
    Wang, Huei
    Hammer, Andrew
    Keech, Anthony C.
    Pedersen, Terje R.
    Giugliano, Robert
    Sabatine, Marc S.
    Bergmark, Brian A.
    CIRCULATION, 2020, 142
  • [29] Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
    McClintick, Daniel J.
    O'Donoghue, Michelle L.
    De Ferrari, Gaetano M.
    Ferreira, Jorge
    Ran, Xinhui
    Im, Kyungah
    Elliott-Davey, Mary
    Wang, Bei
    Monsalvo, Maria Laura
    Atar, Dan
    Keech, Anthony
    Giugliano, Robert P.
    Sabatine, Marc S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (06) : 652 - 664
  • [30] CARDIOVASCULAR BENEFIT OF EVOLOCUMAB IN 27,564 PATIENTS WITH AND WITHOUT AUTOIMMUNE OR INFLAMMATORY DISEASES: AN ANALYSIS OF THE FOURIER TRIAL
    Zimerman, Andre
    Giugliano, Robert P.
    Kunzler, Ana
    Ran, Xinhui
    Murphy, Sabina
    Wang, Huei
    Honarpour, Narimon
    Sabatine, Marc Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1682 - 1682
12345